Search

Your search keyword '"Luciana P. Rangel"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Luciana P. Rangel" Remove constraint Author: "Luciana P. Rangel"
32 results on '"Luciana P. Rangel"'

Search Results

1. PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma

2. Recent Synthetic Approaches towards Small Molecule Reactivators of p53

3. Misfolding, Aggregation and Disordered Segments in c-Abl and p53 in Human Cancer

4. Anticancer Therapeutic Strategies Targeting p53 Aggregation

5. RNA modulates aggregation of the recombinant mammalian prion protein by direct interaction

6. Evaluation of neuroprotective activity of digoxin and semisynthetic derivatives against partial chemical ischemia

7. Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells

8. Recent Synthetic Approaches towards Small Molecule Reactivators of p53

9. Resveratrol prevents p53 aggregation in vitro and in breast cancer cells

10. Balance betweenS-nitrosylation and denitrosylation modulates myoblast proliferation independently of soluble guanylyl cyclase activation

11. Bioactive Compounds and Metabolites from Grapes and Red Wine in Breast Cancer Chemoprevention and Therapy

12. p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells

13. Evaluation of the effect of cafeteria diet on the kidney Na,K-ATPase activity, and oxidative stress

14. Methods to Screen Compounds Against Mutant p53 Misfolding and Aggregation for Cancer Therapeutics

15. Prion protein-coated magnetic beads: Synthesis, characterization and development of a new ligands screening method

16. Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

17. Balance between

18. Putative role of an ABC transporter in Fonsecaea pedrosoi multidrug resistance

19. Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils

20. Methoxy Stilbenes as Potent, Specific, Untransported, and Noncytotoxic Inhibitors of Breast Cancer Resistance Protein

21. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion

22. Oroidin Inhibits the Activity of the Multidrug Resistance Target Pdr5p from Yeast Plasma Membranes

23. Prion-like aggregation of mutant p53 in cancer

24. The aggregation of mutant p53 produces prion-like properties in cancer

25. Biophysical and morphological studies on the dual interaction of non-octarepeat prion protein peptides with copper and nucleic acids

26. Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor

27. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer

28. Isolation of two bioactive diterpenic acids from Copaifera glycycarpa oleoresin by high-speed counter-current chromatography

29. Inhibitory effects of gallic acid ester derivatives on Saccharomyces cerevisiae multidrug resistance protein Pdr5p

30. Efeito de extratos de plantas da Floresta Atlântica Brasileira sobre a atividade da Pdr5p ATPase

31. Continuous vs fractionated violet LED light protocols for dental bleaching: Evaluations of color change and temperature of the dental pulp and buccal surface.

32. New structure–activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity

Catalog

Books, media, physical & digital resources